Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NRDS
NRDS logo

NRDS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy NerdWallet Inc (NRDS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.420
1 Day change
-7.83%
52 Week Range
16.240
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

NerdWallet Inc (NRDS) is not a strong buy for a beginner, long-term investor at this time. Despite its revenue growth, the company's declining net income, EPS, and insider selling trends, combined with a recent downgrade by Morgan Stanley, suggest limited upside potential in the near term. Additionally, technical indicators and options data do not signal a strong bullish sentiment.

Technical Analysis

The MACD is slightly positive but contracting, RSI is neutral at 36.799, and moving averages are converging, indicating no clear trend. The stock is trading near its support level of 10.378, with resistance at 11.138. Short-term price action suggests a 50% chance of a slight decline in the next day (-0.37%) and next week (-0.23%), with a larger potential drop in the next month (-4.74%).

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
5

Positive Catalysts

  • The company has achieved 27.8% annual revenue growth and a strong gross margin of 93.97%, up 3.37% YoY. Its performance in Banking, Loans, and Insurance segments has been strong.

Neutral/Negative Catalysts

  • Insiders are selling heavily, with a 239.76% increase in selling activity over the last month. Morgan Stanley downgraded the stock to Underweight, citing high earnings estimates, constrained liquidity, and limited visibility. The financial sector's underperformance and potential AI disruption in financial services also pose risks.

Financial Performance

In Q4 2025, revenue increased by 22.63% YoY to $225.4M, but net income dropped by 63.73% YoY to $14M. EPS fell by 58.70% YoY to 0.19, reflecting declining profitability despite revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Morgan Stanley downgraded the stock to Underweight with a price target of $9, citing constrained liquidity and limited visibility. Oppenheimer and Truist lowered their price targets to $15 and $18, respectively, but maintain positive ratings based on revenue growth in key segments.

Wall Street analysts forecast NRDS stock price to rise
6 Analyst Rating
Wall Street analysts forecast NRDS stock price to rise
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 9.135
sliders
Low
14
Averages
17
High
19
Current: 9.135
sliders
Low
14
Averages
17
High
19
Truist
Buy
to
Buy
downgrade
$18 -> $15
AI Analysis
2026-05-11
New
Reason
Truist
Price Target
$18 -> $15
AI Analysis
2026-05-11
New
downgrade
Buy
to
Buy
Reason
Truist lowered the firm's price target on NerdWallet to $15 from $18 and keeps a Buy rating on the shares. The company's Q1 results and Q2 guide were both soft due to a direct insurer pulling back on its spend, though these were offset by better performance from Banking and Loans, leading to a comfortable beat on the bottom line on higher marketing efficiency, the analyst tells investors in a research note.
Oppenheimer
Oppenheimer
Outperform
downgrade
$15 -> $12
2026-05-11
New
Reason
Oppenheimer
Oppenheimer
Price Target
$15 -> $12
2026-05-11
New
downgrade
Outperform
Reason
Oppenheimer lowered the firm's price target on NerdWallet to $12 from $15 on lower peer multiples, while keeping an Outperform rating on the shares following quarterly results. The firm is encouraged by continuing LLM traffic share improvement, benefiting channel diversification and conversion. Oppenheimer believes AI disintermediation in financial service products is unlikely considering the legal/regulatory partner structure, likely requiring aggregator partnerships.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NRDS
Unlock Now

People Also Watch